413 related articles for article (PubMed ID: 33228726)
1. Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial.
Wu R; Wei F; Qu L; Bai L; Li J; Li F; Yan W; Wang Q; Wei J
Trials; 2020 Nov; 21(1):951. PubMed ID: 33228726
[TBL] [Abstract][Full Text] [Related]
2. A Prospective, Multicentered, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Keluoxin Capsules in the Treatment of Microalbuminuria in Patients with Type 2 Early Diabetic Kidney Disease.
Zhao J; Wang S; Li X; Zhang G; Xu Y; Zheng X; Guo J; Zhang Z
J Integr Complement Med; 2024 Feb; 30(2):185-195. PubMed ID: 37733303
[No Abstract] [Full Text] [Related]
3. Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial.
Jin D; Huang WJ; Meng X; Yang F; Bao Q; Zhang MZ; Yang YN; Ni Q; Lian FM; Tong XL
Trials; 2019 Dec; 20(1):756. PubMed ID: 31864393
[TBL] [Abstract][Full Text] [Related]
4. Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial.
Liu M; Di YM; Zhang L; Yang L; Zhang L; Chen J; Wang R; Xie X; Lan F; Xie L; Huang J; Zhang AL; Xue CC; Liu X
Front Endocrinol (Lausanne); 2024; 15():1334609. PubMed ID: 38390199
[TBL] [Abstract][Full Text] [Related]
5. Effects of traditional Chinese herbal medicine in patients with diabetic kidney disease: study protocol for a randomized controlled trial.
Wang M; Wang Z; Zhou J; Sun W; Wang Y; Han M; Yang H; Liu WJ; Wang Y
Trials; 2018 Jul; 19(1):389. PubMed ID: 30016983
[TBL] [Abstract][Full Text] [Related]
6. Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.
Yan M; Wen Y; Yang L; Wu X; Lu X; Zhang B; Huang W; Li P
Trials; 2016 May; 17(1):259. PubMed ID: 27216240
[TBL] [Abstract][Full Text] [Related]
7. Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial.
Zhao XM; Zhang Y; He XH; Chen HD; Wang ZF; Guo J; Wang XM; Gao ZZ; Wang JP; Liu W; Zhao LH; Tong XL
Trials; 2018 Mar; 19(1):200. PubMed ID: 29587863
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial.
Li P; Chen Y; Liu J; Hong J; Deng Y; Yang F; Jin X; Gao J; Li J; Fang H; Liu G; Shi L; Du J; Li Y; Yan M; Wen Y; Yang W
PLoS One; 2015; 10(5):e0126027. PubMed ID: 25938778
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial.
Kou J; Wu J; Yang HT; He YN; Fang JA; Deng YY; Xie YS; Nie LF; Lin HL; Cai GY; Chen XM
Trials; 2014 Dec; 15():479. PubMed ID: 25480673
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial.
Wu J; Duan SW; Yang HT; Deng YY; Li W; He YN; Ni ZH; Zhan YL; Lin S; Guo ZY; Zhu J; Fang JA; Liu XS; Wang LH; Wang R; Wang NS; Cheng XH; He LQ; Luo P; Sun SR; Sun JF; Yin AP; Jiang GR; Chen HY; Liu WH; Lin HL; Liang M; Ma L; Chen M; Song LQ; Chen J; Zhu Q; Xing CY; Li Y; Gao JN; Li RS; Li Y; Zhang H; Lu Y; Zhou QL; Fu JZ; He Q; Cai GY; Chen XM
J Integr Med; 2021 Mar; 19(2):111-119. PubMed ID: 33589406
[TBL] [Abstract][Full Text] [Related]
11. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
Li P; Chen YZ; Lin HL; Ni ZH; Zhan YL; Wang R; Yang HT; Fang JA; Wang NS; Li WG; Sun XF; Chen XM
Trials; 2017 Apr; 18(1):170. PubMed ID: 28395659
[TBL] [Abstract][Full Text] [Related]
12. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
Gan J; Wu Y; Gong X; Ma Y; Yu S; Gao J
Trials; 2019 Aug; 20(1):481. PubMed ID: 31391092
[TBL] [Abstract][Full Text] [Related]
13. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
Yang X; Zhang B; Lu X; Yan M; Wen Y; Zhao T; Li P
BMC Complement Altern Med; 2016 Jul; 16():246. PubMed ID: 27460780
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the Shenzhuo formula in the treatment of patients with macroalbuminuria secondary to diabetic kidney disease: protocol update and statistical analysis plan.
Wei Y; Huang YS; Yang Z; Wang X; Li Y; Zhang Y; Zhao LH; Tong X
Trials; 2022 Jan; 23(1):61. PubMed ID: 35057843
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease.
Liao T; Zhao K; Huang Q; Tang S; Chen K; Xie C; Zhang C; Gan W
Medicine (Baltimore); 2020 Jul; 99(31):e21137. PubMed ID: 32756091
[TBL] [Abstract][Full Text] [Related]
16. The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial.
Wang H; Mu W; Zhai J; Xing D; Miao S; Wang J; Deng Y; Wang N; Chen H; Yang H; He X; Shang H
Trials; 2013 Jun; 14():165. PubMed ID: 23738508
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: A multicenter, randomized controlled trial.
Liu J; Gao LD; Fu B; Yang HT; Zhang L; Che SQ; Xu Y; Du X; Liu ZC; Xue Y; Lv CX; Huang YH; Wang BH; Gao SX; Xing YF; Yuan XH
Phytomedicine; 2022 Jun; 100():154079. PubMed ID: 35413644
[TBL] [Abstract][Full Text] [Related]
18. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E1 for preventing the progression of diabetic kidney disease.
Wang H; Deng JL; Yue J; Li J; Hou YB
Cochrane Database Syst Rev; 2010 May; (5):CD006872. PubMed ID: 20464745
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
Zhang L; Li P; Xing CY; Zhao JY; He YN; Wang JQ; Wu XF; Liu ZS; Zhang AP; Lin HL; Ding XQ; Yin AP; Yuan FH; Fu P; Hao L; Miao LN; Xie RJ; Wang R; Zhou CH; Guan GJ; Hu Z; Lin S; Chang M; Zhang M; He LQ; Mei CL; Wang L; Chen X
Am J Kidney Dis; 2014 Jul; 64(1):57-65. PubMed ID: 24631042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
